What is the current valuation of the India inflammatory bowel-disease-treatment market?

The market valuation was $1200.0 Million in 2024. Read More

What is the projected market valuation for the India inflammatory bowel-disease-treatment market by 2035?

The projected valuation for 2035 is $2170.0 Million. Read More

Which companies are the key players in the India inflammatory bowel-disease-treatment market?

Key players include AbbVie, Johnson & Johnson, Bristol-Myers Squibb, Takeda Pharmaceutical Company, Amgen, Gilead Sciences, Merck & Co., Sanofi, and Ferring Pharmaceuticals. Read More

What are the main segments of the India inflammatory bowel-disease-treatment market?

The main segments include Type, Route of Administration, Disease Type, and End User. Read More

What is the market size for biologics in the India inflammatory bowel-disease-treatment market?

The market size for biologics ranges from $400.0 Million to $800.0 Million. Read More

How does the market size for Crohn's Disease compare to Ulcerative Colitis in the India inflammatory bowel-disease-treatment market?

The market size for Crohn's Disease ranges from $600.0 Million to $1070.0 Million, while Ulcerative Colitis ranges from $600.0 Million to $1100.0 Million. Read More

What is the market size for oral administration in the India inflammatory bowel-disease-treatment market?

The market size for oral administration is projected to range from $600.0 Million to $1100.0 Million. Read More

Which end user segment has the highest market size in the India inflammatory bowel-disease-treatment market?

The Hospitals segment has the highest market size, ranging from $600.0 Million to $1100.0 Million. Read More

What is the market size range for immunomodulators in the India inflammatory bowel-disease-treatment market?

The market size for immunomodulators ranges from $250.0 Million to $460.0 Million. Read More

India Inflammatory Bowel Disease Treatment Market

Q: What is the expected CAGR for the India inflammatory bowel-disease-treatment market during the forecast period 2025 - 2035?

The expected CAGR is 5.53% during the forecast period. Read More

ID: MRFR/MED/54713-HCR

200 Pages

Satyendra Maurya

Last Updated: February 06, 2026

India Inflammatory Bowel Disease Treatment Market Research Report: Size, Share, Trend Analysis By Drug Type (Aminosalicylates, Corticosteroids, Immunomodulators, Biologics, Antibiotics), By Route of Administration (Oral, Injectable, Topical), By Disease Type (Ulcerative Colitis, Crohn's Disease) and By End Users (Hospitals, Ambulatory Surgical Centers, Homecare Settings) - Growth Outlook & Industry Forecast 2025 To 2035

India Inflammatory Bowel Disease Treatment Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Type (USD Million)
  1. 4.1.1 Aminosalicylates
  2. 4.1.2 Corticosteroids
  3. 4.1.3 Immunomodulators
  4. 4.1.4 Biologics
  5. 4.1.5 Antibiotics
2. 4.2 Medical Device, BY Route of Administration (USD Million)
  1. 4.2.1 Oral
  2. 4.2.2 Injectable
  3. 4.2.3 Topical
3. 4.3 Medical Device, BY Disease Type (USD Million)
  1. 4.3.1 Ulcerative Colitis
  2. 4.3.2 Crohn's Disease
4. 4.4 Medical Device, BY End User (USD Million)
  1. 4.4.1 Hospitals
  2. 4.4.2 Ambulatory Surgical Centers
  3. 4.4.3 Homecare Settings
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 AbbVie (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Johnson & Johnson (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Bristol-Myers Squibb (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Takeda Pharmaceutical Company (JP)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Amgen (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Gilead Sciences (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Merck & Co. (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Sanofi (FR)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Ferring Pharmaceuticals (CH)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 INDIA MARKET ANALYSIS BY TYPE
3. 6.3 INDIA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
4. 6.4 INDIA MARKET ANALYSIS BY DISEASE TYPE
5. 6.5 INDIA MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 MEDICAL DEVICE, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY ROUTE OF ADMINISTRATION, 2024 TO 2035 (USD Million)
16. 6.16 MEDICAL DEVICE, BY DISEASE TYPE, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY DISEASE TYPE, 2024 TO 2035 (USD Million)
18. 6.18 MEDICAL DEVICE, BY END USER, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Million)
  3. 7.2.3 BY DISEASE TYPE, 2025-2035 (USD Million)
  4. 7.2.4 BY END USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

India Medical Device Market Segmentation

Medical Device By Type (USD Million, 2025-2035)

Aminosalicylates
Corticosteroids
Immunomodulators
Biologics
Antibiotics

Medical Device By Route of Administration (USD Million, 2025-2035)

Oral
Injectable
Topical

Medical Device By Disease Type (USD Million, 2025-2035)

Ulcerative Colitis
Crohn's Disease

Medical Device By End User (USD Million, 2025-2035)

Hospitals
Ambulatory Surgical Centers
Homecare Settings

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”